Work

Clinical Evidence for the Microbiome in Inflammatory Diseases

Year: 2017

Type: review

Abstract: Clinical evidence is accumulating for a role of the microbiome in contributing to or modulating severity of inflammatory diseases. These studies can be organized by various organ systems involved, as well as type of study approach utilized, whether investigators compared the microbiome of cases versus controls, followed patients longitudinally, or intervened with antibiotics, prebiotics, or bacterial introduction. In this review, we summarize the clinical evidence supporting the microbiome as an important mechanism in the onset and maintenance of inflammation.

Source: Frontiers in Immunology

DOI: 10.3389/fimmu.2017.00400

Authors: Ann E. Slingerland, Zaker Schwabkey, Diana H. Wiesnoski, Robert R. Jenq

Institutions: Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Gut microbiota and health

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,801